RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Myriad Genetics Stock

Myriad Genetics Liabilities 2025

Myriad Genetics Liabilities

326.5 M USD

Ticker

MYGN

ISIN

US62855J1043

WKN

897518

In 2025, Myriad Genetics's total liabilities amounted to 326.5 M USD, a -10.13% difference from the 363.3 M USD total liabilities in the previous year.

Myriad Genetics Aktienanalyse

What does Myriad Genetics do?

Myriad Genetics Inc. is a biotechnology company specializing in the research of cancer and genetic analysis technologies. The company was founded in 1991 by Mark Skolnick and has since become a global leader in personalized medicine and diagnostics. It is headquartered in Salt Lake City, Utah, USA, and employs over 2,400 employees worldwide. Myriad Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Myriad Genetics's Liabilities

Myriad Genetics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Myriad Genetics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Myriad Genetics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Myriad Genetics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Myriad Genetics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Myriad Genetics stock

What is the level of liabilities of Myriad Genetics this year?

Myriad Genetics has a debt balance of 326.5 M USD this year.

What were the liabilities of Myriad Genetics compared to the previous year?

The liabilities of Myriad Genetics have increased by -10.13% dropped compared to the previous year.

What are the consequences of high debt for investors of Myriad Genetics?

High liabilities can pose a risk for investors of Myriad Genetics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Myriad Genetics?

Low liabilities mean that Myriad Genetics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Myriad Genetics affect the company?

An increase in liabilities of Myriad Genetics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Myriad Genetics affect the company?

A decrease in the liabilities of Myriad Genetics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Myriad Genetics?

Some factors that can influence the liabilities of Myriad Genetics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Myriad Genetics so important for investors?

The liabilities of Myriad Genetics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Myriad Genetics take to modify the liabilities?

To change its liabilities, Myriad Genetics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Myriad Genetics pay?

Over the past 12 months, Myriad Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Myriad Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Myriad Genetics?

The current dividend yield of Myriad Genetics is .

When does Myriad Genetics pay dividends?

Myriad Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Myriad Genetics?

Myriad Genetics paid dividends every year for the past 0 years.

What is the dividend of Myriad Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Myriad Genetics located?

Myriad Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Myriad Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Myriad Genetics from 10/9/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/9/2025.

When did Myriad Genetics pay the last dividend?

The last dividend was paid out on 10/9/2025.

What was the dividend of Myriad Genetics in the year 2024?

In the year 2024, Myriad Genetics distributed 0 USD as dividends.

In which currency does Myriad Genetics pay out the dividend?

The dividends of Myriad Genetics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Myriad Genetics

Our stock analysis for Myriad Genetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Myriad Genetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.